REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27/10/2025
Voltar para busca
Dado oficial do USPTO
ENDOCEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ENDOCEUTICS
ST13
US500000077880488Classe
5, 35, 40, 41, 42
Pedido
77880488
Registro
6181907
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
123
Atualização mais recente
28/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 40, 41, 42
Data de depósito
25/11/2009
Data de registro
27/10/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/10/2020
Última transação
28/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Quebec City, QUÉBEC, CA
Examinador
POWELL, LINDA
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Endoceutics Inc.
Representantes
Michael J. Leonard Fox Rothschild LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 40Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substances for the prevention and treatment of menopause, sexual dysfunction, vaginal atrophy, decreased libido, gynaecological disorders; Pharmaceutical preparations and substances for the prevention and treatment of menopausal problems, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia; Pharmaceutical preparations and substances for the treatment of the endocrine system; Pharmaceutical preparations and substances for the prevention and treatment of oily skin, acne, male baldness; Pharmaceutical preparations and substances for the prevention and treatment of obesity, high cholesterol, diabetes, loss of muscle and mass strength, bone loss
Classe 35
Wholesale distributorship of pharmaceuticals for others
Classe 40
Custom manufacture of pharmaceutical products to the order and specification of others
Classe 41
Pharmaceutical educational services and patient educational services, namely, providing classes, workshops and seminars in the field of treatment and prevention of endocrine-related disorders and diseases
Classe 42
Research and development in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
123 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
27/10/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
17/09/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
06/05/2020
APET
ASSIGNED TO PETITION STAFF
04/05/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/04/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
17/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2020
PUBO
PUBLISHED FOR OPPOSITION
10/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/02/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
03/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/02/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/02/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/02/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/02/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/02/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
31/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/01/2020
ATRV
ATTORNEY REVIEW COMPLETED
24/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/01/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/11/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/11/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/11/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/05/2019
GNSL
LETTER OF SUSPENSION E-MAILED
15/05/2019
CNSL
SUSPENSION LETTER WRITTEN
15/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
29/04/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
29/10/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
29/10/2018
CNSI
SUSPENSION INQUIRY WRITTEN
29/10/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
25/10/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
22/03/2018
GNSL
LETTER OF SUSPENSION E-MAILED
22/03/2018
CNSL
SUSPENSION LETTER WRITTEN
22/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2018
ALIE
ASSIGNED TO LIE
08/03/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/03/2018
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/09/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/09/2017
CNSI
SUSPENSION INQUIRY WRITTEN
09/09/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/09/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/03/2017
GNSL
LETTER OF SUSPENSION E-MAILED
02/03/2017
CNSL
SUSPENSION LETTER WRITTEN
02/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/02/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/02/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
13/08/2016
GNSI
INQUIRY TO SUSPENSION E-MAILED
13/08/2016
CNSI
SUSPENSION INQUIRY WRITTEN
13/08/2016
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/08/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/02/2016
GNSL
LETTER OF SUSPENSION E-MAILED
04/02/2016
CNSL
SUSPENSION LETTER WRITTEN
04/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/01/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
22/01/2016
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
22/07/2015
GNSI
INQUIRY TO SUSPENSION E-MAILED
22/07/2015
CNSI
SUSPENSION INQUIRY WRITTEN
22/07/2015
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
15/07/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/01/2015
GNSL
LETTER OF SUSPENSION E-MAILED
15/01/2015
CNSL
SUSPENSION LETTER WRITTEN
15/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/12/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/12/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/12/2014
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
24/12/2014
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
26/06/2014
GNSI
INQUIRY TO SUSPENSION E-MAILED
26/06/2014
CNSI
SUSPENSION INQUIRY WRITTEN
26/06/2014
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
24/06/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
18/12/2013
GNSL
LETTER OF SUSPENSION E-MAILED
18/12/2013
CNSL
SUSPENSION LETTER WRITTEN
18/12/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/12/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/12/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/12/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/12/2013
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/12/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/06/2013
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/06/2013
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/06/2013
CNSI
SUSPENSION INQUIRY WRITTEN
03/06/2013
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/11/2012
GNSL
LETTER OF SUSPENSION E-MAILED
08/11/2012
CNSL
SUSPENSION LETTER WRITTEN
08/11/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2012
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
25/10/2012
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
28/04/2012
GNSI
INQUIRY TO SUSPENSION E-MAILED
28/04/2012
CNSI
SUSPENSION INQUIRY WRITTEN
28/04/2012
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
23/04/2012
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
19/10/2011
GNSL
LETTER OF SUSPENSION E-MAILED
19/10/2011
CNSL
SUSPENSION LETTER WRITTEN
19/10/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/09/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/09/2011
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/09/2011
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/03/2011
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/03/2011
CNSI
SUSPENSION INQUIRY WRITTEN
11/03/2011
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/03/2011
ALIE
ASSIGNED TO LIE
09/03/2011
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/09/2010
GNSL
LETTER OF SUSPENSION E-MAILED
09/09/2010
CNSL
SUSPENSION LETTER WRITTEN
09/09/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/04/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/03/2010
GNRT
NON-FINAL ACTION E-MAILED
08/03/2010
CNRT
NON-FINAL ACTION WRITTEN
08/03/2010
DOCK
ASSIGNED TO EXAMINER
02/03/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2009
NWAP
NEW APPLICATION ENTERED
28/11/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENDOCEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.